Article info
PDFReview
Statin-related myopathies
- Correspondence to Dr David Hilton-Jones, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, OX3 9DU, UK; david.hilton-jones{at}ndcn.ox.ac.uk
Citation
Statin-related myopathies
Online issue publication
March 27, 2018
Article Versions
- Previous version (27 March 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Investigating raised creatine kinase
- Statin-induced myopathy prevented by creatine administration
- Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patients
- Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy?
- Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin
- Proximal myopathy: diagnostic approach and initial management
- Toxic and drug-induced myopathies
- Immune-mediated necrotising myopathy: a rare cause of hyperCKaemia
- Autoimmune necrotising myopathy and HMGCR antibodies
- Metabolic myopathies: a practical approach